Shows
The Patient SignalTrump Urges GOP Flexibility on Abortion; Biobeat's Cuffless Monitor & Insilico-Servier AI DealIn this episode, we delve into recent developments in politics, health care, and technology. Former President Donald Trump has called on Republicans to adopt a more flexible approach to abortion restrictions to secure a health care deal, emphasizing the need for compromise to achieve broader legislative goals. Meanwhile, Biobeat Technologies has raised $50 million to introduce its innovative cuffless blood pressure monitor to the U.S. market, despite skepticism from cardiovascular health bodies. Lastly, Insilico Medicine has partnered with Servier in a groundbreaking $888 million collaboration to leverage AI for drug discovery, highlighting the growing role of technology in the pharmaceutical...
2026-01-0804 min
Artificial Intelligence Act - EU AI ActEuropean Union Reworks AI Landscape as Transparency Rules LoomImagine this: it's late December 2025, and I'm huddled in my Berlin apartment, laptop glowing amid the winter chill, dissecting the whirlwind around the European Union's Artificial Intelligence Act. The EU AI Act, that risk-based behemoth enforced since August 2024, isn't just policy—it's reshaping how we code the future. Just days ago, on December 17th, the European Commission dropped the first draft of its Code of Practice on Transparency for AI-generated content, straight out of Article 50. This multi-stakeholder gem, forged with industry heavyweights, academics, and civil society from across Member States, mandates watermarking deepfakes, labeling synthetic videos, and embedding detection tools in...
2025-12-2903 minArtificial Intelligence Act - EU AI ActHeadline: Turbulence in EU's AI Fortress: Delays, Lobbying, and the Future of AI RegulationImagine this: it's late December 2025, and I'm huddled in my Berlin apartment, laptop glowing amid the winter chill, dissecting the EU AI Act's latest twists. Listeners, the Act, that landmark law entering force back in August 2024, promised a risk-based fortress against rogue AI—banning unacceptable risks like social scoring systems since February 2025. But reality hit hard. Economic headwinds and tech lobbying have turned it into a halting march.Just days ago, on December 11, the European Commission dropped its second omnibus package, a digital simplification bombshell. Dubbed the Digital Omnibus, it proposes a Stop-the-Clock mechanism, pausing high-risk AI compliance—orig...
2025-12-2703 min
The BioWorld Insider PodcastFinding a better, longer-lasting fix in opioid overdoseThe opioid crisis may not be front and center anymore, but it's raging still. A major problem is that overdose-reversal drugs don't last long enough to help users who opt out of hospital treatment after they are revived. Elysium Therapeutics Inc. CEO Greg Sturmer talks with Randy Osborne about his firm's candidate for a solution to the medical and societal problem. The NIH – which has been helpful to Elysium since the company's founding – the FDA, and others are working to advance a longer-lasting reversal agent. Experiments already done with approved reversers, as well as computer modeling that's been used by re...
2025-12-1040 min
Conversations from LSIPerspectives from the Press | LSI Europe '25This Workshop took place at LSI Europe ‘25 Emerging Medtech Summit in London.Join leading medtech journalists from BioBiz Buzz, BioWorld MedTech, and Medtech Insight as they share industry insights and discuss current trends shaping the medical technology landscape.This Workshop featured:Mike Ward — BioBiz BuzzShani Alexander — BioWorld MedTechNatasha Barrow — Medtech InsightJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social:LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Spotify: https://open.spotify.com/show/7LnmGOwBMmRHJeDXmv3KEI?si=a93200169a884c09Subscrib...
2025-11-1842 min
The BioWorld Insider PodcastEsperion Therapeutics CEO Sheldon KoenigStarting with the Clear Outcomes study in 2023, which gave Esperion Therapeutics immediate success with more than 1 billion impressions globally, the company has been creating a pipeline to keep its positive momentum going. Esperion developed and is commercializing the only U.S. FDA approved oral, once-daily, non-statin medicines for primary and secondary prevention of cardiovascular disease in patients struggling with elevated LDL cholesterol. BioWorld Insider guest Sheldon Koenig, Esperion's CEO, views the company as a cardiometabolic drug developer that is working to treat and possibly cure primary sclerosing cholangitis so patients can avoid having to get a liver transplant. "All o...
2025-11-1219 minConversations from LSIScaling Diagnostics: From Innovation to Infrastructure | LSI Asia '25This Panel took place at LSI Asia ‘25 Emerging Medtech Summit in Singapore.This panel examines how innovative diagnostic technologies can be scaled and integrated into healthcare infrastructure, featuring expert perspectives on overcoming real-world implementation challenges.This Panel featured:Adrian Piers Yan Yue Cheong — Partner, Bioworld VenturesPeter Fischer — CEO, Inkspace ImagingChristina Vallgren — CEO / co-founder, TerapetJeremy Au — Chief Operating Officer, LucenceLohendran Baskaran — Director, CVS.AI Research Lab, National Heart Centre SingaporeJoin us at our ne...
2025-09-1231 min
The BioWorld Insider PodcastTrying this at home: Bioxcel steps closer to an sNDA for Igalmi – AUDIO Bioxcel Therapeutics Inc.'s phase III results in bipolar disorders or schizophrenia could bring Igalmi (BXCL-501) out of the clinic and into patients' homes for easier treatment. Vimal Mehta, Bioxcel CEO, talks about the potential with Lee Landenberger in the latest BioWorld Insider podcast.
2025-08-2909 min
The BioWorld Insider PodcastTrying this at home: Bioxcel steps closer to an sNDA for Igalmi – VIDEO Bioxcel Therapeutics Inc.'s phase III results in bipolar disorders or schizophrenia could bring Igalmi (BXCL-501) out of the clinic and into patients' homes for easier treatment. Vimal Mehta, Bioxcel CEO, talks about the potential with Lee Landenberger in the latest BioWorld Insider podcast.
2025-08-2709 min
Wow in the WorldA Weekend at BioWorld (8/11/25)Ding ding ding! Mindy and Guy win big on Bongo and the Big Toots morning radio show, their prize? A weekend away at a state of the art research facility in the middle of the desert! Even better, they're allowed to bring along 4 of their closest friends/neighbors. What could possibly go wrong? It's the who, when, why, how and WOW of life sized terrariums! Originally aired 10/14/24.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
2025-08-1122 min
The MedTech Monitor PodcastEpisode #06 - Telehealth Security: Best Practices for Virtual CareTelehealth isn’t just convenient—it’s a new attack surface for ePHI. In this episode, we'll walk through the end-to-end security controls every virtual care program needs:
Choosing a fully HIPAA-compliant platform with end-to-end encryption and a solid BAA
Strong patient authentication with identity proofing and multi-factor requirements
Secure handling of session recordings, transcripts, and chat logs—encrypted at rest and in transit
Staff training on private-session etiquette and quarterly security drills
Building a telehealth-specific incident response playbook and real-time monitoring rules
MEDTECH MINUTE STORIES
2025-06-2325 min
The MedTech Monitor PodcastEpisode #03: AI In Family Practice: Enhancing Diagnostics & WorkflowThis week, Will explores how AI is transforming family practice from diagnostic decision support to workflow automation.
You’ll hear how tools like smart symptom checkers and portable image-analysis apps catch disease earlier, and how AI scribes and coding assistants can shave 20–30 percent off documentation time.
We also address ethical and HIPAA considerations, including bias, data privacy, and liability, and share a step-by-step playbook for piloting AI in your clinic.
Listen in to learn how to kickstart your own AI pilot and measure real outcomes.
Episode #03 Links to Sources
1. AI...
2025-06-0230 min
The BioWorld Insider PodcastThe importance of balancing AI and people in drug developmentMore and more, artificial intelligence is becoming inseparable from drug development. But it needs to be well integrated with the right people and support technologies in order to be successful, according to Josep Bassaganya-Riera, the founder and CEO of Nimmune Biopharma Inc. Nimmune has leveraged methods of AI-enabled drug discovery to develop a number of late-stage therapeutics using a strategic model Bassaganya-Riera first developed at Landos Biopharma Inc., a previous venture which was sold to Abbvie in 2024. As the founder of several other companies, Bassaganya-Riera has more than 20 years in the industry and he shared his insights and experience...
2025-05-2721 min
The BioWorld Insider PodcastTwo CEOs discuss bracing for tariffs, NIH grant cuts and gifting China biopharma leadership position As pharma deals with the impact of NIH grant cuts and what could follow with the imposition of tariffs, Robert Williamson, CEO of Triumvira Immunologics Inc., and Hernan Bazan, CEO of South Rampart Pharma LLC, brought their extensive experience in the industry to the podcast. Their concerns include how tariffs will bring lower margins for U.S. companies, higher costs and eventually drug shortages. They also spoke about the impact on drug development as more than 90% of all drugs are NIH-supported and the challenges private investment faces as it steps in to fill the gap. "What we're doing by f...
2025-04-2331 min
The BioWorld Insider PodcastAs biopharma investments stumble, med tech surgesThe biopharma sector is still trying to get its wind and resume its once-powerful investment ways. Medical technology has sidestepped much of biopharma's issues by being more flexible along the development path, according to BioWorld MedTech Editor Annette Boyle in this edition of the podcast. This year's med-tech investment numbers have improved over those from last year and the year before by bringing in $2.76 billion by financing 56 transactions in January alone. Boyle described the current financing climate on the newest BioWorld Insider podcast and explained why the sector is performing well year to date.
2025-03-3012 min
The BioWorld Insider PodcastMega money well spent? Mammoth mergers fall short of the dreamBillion-dollar M&As are commonplace now, but not too long ago they were a rarity. So many have occurred in the past few years, they've become the norm. But were all these multi-billion-dollar mega mergers worth the money? Karen Carey, BioWorld's senior managing editor and chief analyst, crunched the numbers on 21 of the biggest M&As in a three-part BioWorld series and found very few have been, so far, good deals for the buyer. In this podcast, Carey sifts through the winners and losers and explains the analysis.
2025-02-2419 min
A Friend for the Long Haul: A Long Covid PodcastClearing the Airwaves: A Long COVID Conversation with @kd_kineticA Friend for the Long Haul - A Long Covid Podcast 100% produced by a disabled Covid long hauler. If you'd like to support my work, please check out the following ways you can do so:My Amazon wish list, which currently focuses on low-spoon activities for my family this summer. We have four kiddos, with three kids who are also navigating disabilities. You can also visit my new Amazon storefront, where I share only the items I use, love, or highly recommend. If you use my links to buy products you already purchase from Amazon, they'll throw me a few pennie...
2024-12-171h 55
The BioWorld Insider PodcastHealing the health divide for womenAs a new BioWorld investigative report shows, decades of research excluding women from clinical trials and investment decisions made in male-dominated boardrooms have led to half the world's health needs being underserved. Of the drug development companies working on women's health solutions, the proportion of funding and partnering for the sector is quite small. But it's slowly growing, as is the depth of science. Karen Carey, BioWorld's managing editor and chief analyst, and the managing editor of Bioworld Science, Anette Breindl, join this episode of the BioWorld Insider podcast to talk about the business and the science of women's...
2024-11-2220 min
The BioWorld Insider PodcastModifi gets creative on the rocky road to a multibillion-dollar buyoutModifi Biosciences Inc. was recently acquired by Merck & Co. Inc. for $30 million up front. Modifi shareholders could receive milestones of up to $1.3 billion. It all happened in the dizzyingly short span of a little more than two years. Modifi's founder, Ranjit Bindra, and a small group of advisers brought the company through preclinical work on DNA repair for treating glioblastoma and then twice faced running out of money and shutting down the company. Confounding the typical wisdom, Bindra and co-founder Kevin Rakin ended up putting the Merck deal together all by themselves. "People would actually ask, 'Who is your...
2024-11-1323 min
The BioWorld Insider PodcastA quantum leap into the future of drug developmentIn the newest BioWorld Insider podcast, Victoria Lipinska, the America's lead for Quantum Innovation Centers at IBM Quantum, talks about the future of drug development using quantum computing. "The new technology is a completely different branch of computing as opposed to what we know right now, and it's meant to complement what we know, not to really replace it," she said. Quantum computing could lead to more efficient drug discovery by identifying promising compounds faster, understanding their effects at the molecular level and then reducing the need for costly or time-consuming lab experiments. Lipinska is...
2024-10-1717 min
Wow in the WorldA Weekend at BioWorld (10/14/24)GROWNUPS, you can find the WOW of the Wow in the World Light Up Terrarium at amazon.com/wonderykids!Ding ding ding! Mindy and Guy win big on Bongo and the Big Toots morning radio show, their prize? A weekend away at a state of the art research facility in the middle of the desert! Even better, they're allowed to bring along 4 of their closest friends/neighbors. What could possibly go wrong? It's the who, when, why, how and WOW of life sized terrariums!See Privacy Policy at https://art19.com/privacy and California Privacy...
2024-10-1422 min
The Medical Alley Podcast (Presented by MentorMate)Market Access for Groundbreaking Treatments – A Case Study of Pulsed Field Ablation (PFA) with ClarivateNavigating the complexities of groundbreaking treatments can create headwinds. With innovations like Pulsed Field Ablation (PFA) at the forefront, challenges such as financial uncertainties, regulatory shifts, and global adoption become paramount. Join us for an insightful discussion on how global partners address these challenges, focusing on safety & efficacy, financial impacts, and clinical differentiation in areas where baseline data is scarce. Background on PFA: Pulsed Field Ablation (PFA) is a groundbreaking nonthermal energy source that is rapidly transforming atrial fibrillation (AF) treatment, affecting up to 38 million people worldwide. Unlike traditional heat or cold methods, PFA uses high-voltage electrical f...
2024-10-0955 min
The BioWorld Insider PodcastGene and cell therapies will propel innovation, says Astellas CCOGene and cell therapies will drive innovation for the next 10 years, Claus Zieler, the chief commercial officer at Astellas Pharma Inc., said in this episode of the BioWorld Insider podcast. Developers are on the cusp of breakthroughs because a gene can now be replaced "and that means we can potentially cure a disease rather than intervening in a disease." Zieler also shared his thoughts on creating sustainable health care in aging societies, the innovation cycle gap between the U.S. and Europe, and how collaboration between business and government is critical in forging ahead in this wide-ranging discussion.
2024-10-0727 min
The BioWorld Insider PodcastCapricor's CEO pursues a BLA and talks rare diseaseCapricor Therapeutics Inc. just wrapped up a visit with the U.S. FDA and is prepping to file a BLA in October for its Duchenne muscular dystrophy treatment. Linda Marbán, Capricor's CEO, is the guest on the newest BioWorld Insider podcast and she talks about deramiocel (CAP-1002), the company's allogeneic cardiac-derived cell therapy, for treating the rare disease and how the FDA has made strong efforts in helping lay the groundwork for deramiocel. Marbán has been working on the Duchenne treatment for many years and she has strong insights into how to tackle a rare disease development pro...
2024-09-2715 min
The BioWorld Insider PodcastThe first half of 2024 was strong as M&As and financings dominateKaren Carey, BioWorld managing editor and chief analyst, takes a look at the numbers from the first half of 2024. She finds the first six months to be healthy for the biopharma market while the rest of the year is populated with question marks that include the U.S. presidential election and potential interest rate cuts.
2024-07-2618 min
The BioWorld Insider PodcastThe cost of delays in development and sales: It's probably not what you thinkTwo costs of developing drug candidates have been upended by new research from the Tufts University School of Medicine's Center for the Study of Drug Development. New data have produced some very different numbers than you might expect in the cost of a single day of a clinical trial and of missing a day to generate prescription drugs sales. The center's director, Ken Getz, spoke to the BioWorld Insider podcast about updating the outdated numbers and what it means for companies and investors.
2024-07-1716 min
Girl Wonder Webtoon PodcastLore Olympus is over and we have a lot of feelings! Featuring Lore OlymPOD!Zoey & Erin from Lore OlymPOD are joining us on the podcast to discuss the end of Lore Olympus! We're discussing the ending of the series, the fashion, the LO merch we have, the other webtoons we're reading, and so much more!
LORE OLYMPUS IN PRINT:
www.loreolympusbooks.com
HEROES AND VILLAINS MERCH: heroesvillains.com/collections/lore-olympus
SUPPORT LOREOLYMPOD:
www.loreolympod.com
www.instagram.com/loreolympod
www.twitter.com/loreolympod
MY PATREON FOR EARLY ACCESS: www.patreon.com/girlwonder
LORE OLYMPUS SWEATER (THAT I OWN):
https://www.amazon.com/Bioworld-WEBTOON-Olympus-Characters-Sweatshirt-Large/dp/B0CBCMWXRN/ref=sr_1_1?crid=3GXRXIH36JXEE&dib=eyJ2IjoiMSJ9.B1...
2024-06-1646 min
Girl Wonder Webtoon PodcastTHE END OF LORE OLYMPUS with Creator Rachel SmytheMy friends, we've reached the final episode of Lore Olympus. I can barely process it. It's the end of an era. On the podcast, we have the creator of Lore Olympus, Rachel Smythe, discussing:
* How it felt to end the series
* Why she'd like to issue a formal apology to the audience of the New York Comic Con
* The fashion moments at the end of the series
* What's next!
LORE OLYMPUS IN PRINT:
www.loreolympusbooks.com
HEROES AND VILLAINS MERCH: heroesvillains.com/collections/lore-olympus
MY PATREON FOR EARLY ACCESS: www.patreon.com/girlwonder
LORE OLYMPUS SWEATER (THAT I OWN):
https://ww...
2024-06-031h 06
The BioWorld Insider PodcastASCO preview: ADCs and radiotherapies at the forefront of this year's conferenceChris Barden, a co-managing partner at MPM Bioimpact who manages the firm's Bioimpact Equities and Oncology Impact funds, shares her insights into the upcoming American Society of Clinical Oncology (ASCO) conference in Chicago. She talks about the major trends in oncology, including development of antibody drug conjugates, which is currently the hottest area in cancer treatment. Another highlight she expects from ASCO will be development in radiotherapy treatments, particularly in prostate cancer. Bardon provides a guide for attendees to use in setting their schedules for the year's biggest cancer conference and what to watch for in the future.
2024-05-3013 min
The BioWorld Insider PodcastFibrobiologics walks the unconventional financing pathA non-traditional route for financing has been the path to success for Fibrobiologics Inc. In the newest BioWorld Insider podcast, CEO Pete O'Heeron offers insight into the company's unusual path to a Nasdaq listing in January. SPACs, reverse mergers and traditional IPOs weren't attractive enough for Fibrobiologics' management or board, so they decided to go public through a direct listing with no banks as underwriters. It took about seven months to get the company ready for its listing, an around-the-clock effort that O'Heeron said was worth the effort. "We couldn't be more happy with the outcome," he said.
2024-05-1518 min
The BioWorld Insider PodcastBack to fundamentals: The latest numbers point to better timesBioWorld Managing Editor Karen Carey joins the podcast to talk about the numbers from the first quarter of 2024, along with a look back at some 2023 deals and indicators that signal better times are on the way. Financings for the quarter were better than expected, sporting some of the best numbers of the past 13 years. It's part of a larger trend, Carey says, of investors being a lot pickier about where they put their money and demanding better data. The result is a strengthened market and a better outlook.
2024-05-0621 min
Girl Wonder Webtoon PodcastAll I Want To Do Is See You Turn Into A Giant Woman - Lore Olympus RECAP & AnalysisOkay, Hera! Also Melinoe explains how she was born and we go on a deep dive through the times Melinoe has appeared in the comic! Discussing eps 271-273 of Lore Olympus by Rachel Smythe!
LORE OLYMPUS IN PRINT:
www.loreolympusbooks.com
HEROES AND VILLAINS MERCH: heroesvillains.com/collections/lore-olympus
MY PATREON FOR EARLY ACCESS: www.patreon.com/girlwonder
THE SWEATER JILLIAN AND I BOTH WORE DURING THIS PODCAST:
https://www.amazon.com/Bioworld-WEBTOON-Olympus-Characters-Sweatshirt-Large/dp/B0CBCMWXRN/ref=sr_1_1?crid=3GXRXIH36JXEE&dib=eyJ2IjoiMSJ9.B1b4IAMtI5PfB1wkovteDwKXXjNbU3N9o-sAx3-_X-SKLu0fUwGo2CMwfgRDCzQGbsFjFFATqOIGFoKjbHPR2A0w1rt8p-Tp9P2Wu...
2024-04-2829 min
The BioWorld Insider PodcastMark McKenna storms back with Mirador and eyes the development landscapeIn one of the biggest financings of the year so far, former Prometheus Biosciences Inc. CEO Mark McKenna helped raise $400 million to launch a new company, Mirador Therapeutics Inc. He didn't sit on the sidelines for long after Merck & Co. Inc. bought Prometheus for $10.8 billion in 2023. He recruited key Prometheus executives to focus on Mirador's genetic approach to drug discovery and precision medicine. McKenna said there was too much left undone to just hang back. In this BioWorld Insider episode, he talks about the new company and the multi-billion-dollar drugs that he believes provide sub-optimal efficacy compared to the...
2024-04-2325 min
The BioWorld Insider PodcastBiopharma execs seek to avoid pain points in AI integrationBecause artificial intelligence is such a new technology it comes with a mountain of unknowns. Integrating it into a pharmaceutical company presents a unique series of challenges, as a new survey from Verix shows. The report is based on responses from directors, vice presidents and C-suite executives in sales, marketing and brand management at pharmaceutical companies in the U.S. that have more than $100 million in annual revenue. Doron Aspitz, the CEO of Verix, talked about the new findings with the BioWorld Insider podcast and the profound shift that executives face as the new technology takes over an entire ind...
2024-04-1619 min
Girl Wonder Webtoon Podcast"I KNOW SHE LOVES ME" 💕😭 - Lore Olympus RECAP & ANALYSIS with special guest Jillian!A jam-packed episode discussing Hera’s vision of her own death, Hera’s relationship with Echo, Hades and Melinoe, and what the heck is little Dionysus up to? We're analyzing episodes 268-270 of Lore Olympus by Rachel Smythe! Joining me on the podcast is Jillian!
LORE OLYMPUS IN PRINT:
www.loreolympusbooks.com
HEROES AND VILLAINS MERCH: heroesvillains.com/collections/lore-olympus
MY PATREON FOR EARLY ACCESS: www.patreon.com/girlwonder
THE SWEATER JILLIAN AND I BOTH WORE DURING THIS PODCAST:
https://www.amazon.com/Bioworld-WEBTOON-Olympus-Characters-Sweatshirt-Large/dp/B0CBCMWXRN/ref=sr_1_1?crid=3GXRXIH36JXEE&dib=eyJ2IjoiMSJ9.B1b4IAMtI5PfB1wkovteDwKXXjNbU3N9o-sA...
2024-04-151h 47
The BioWorld Insider PodcastSix biopharma executives consider a tough 2023 and are hopeful for a better 2024One aspect of 2023 our group of executives completely agreed on: the past year was tough financially. And they all foresee a more vibrant year ahead for the market. Giving all of them hope were technological breakthroughs such as artificial intelligence, game changing weight loss drugs, the surging fascination with ADCs and hope for lower interest rates. But uncertainty looms about the upcoming general election in the U.S. and ground-shifting gene therapies. In a preview of the annual Biotech Showcase conference, an investor conference for private and micro- to mid-cap biotech companies Jan. 8-10 in San Francisco, BioWorld spoke...
2023-12-1117 min
The BioWorld Insider PodcastAI: driving drug development from effective to remarkableGoogle's Scott Penberthy joins the podcast for a visionary discussion that scans the horizon for startling changes artificial intelligence will bring to drug development in the relatively near future. Among the gems and eyebrow raisers is talk of dramatic reductions in the time it takes to identify the right molecule for development and how digital clinical trials in the not-too-distant future will substantially shrink study times. This episode also provides a preview of the annual Biofuture conference. Each year, a group of trailblazers, disruptors and forward-thinking executives converge to evaluate and forecast the future of health care. This year, Bi...
2023-09-0626 min
The Feminine Founder17:{Interview} Creating Brand Awareness with Rachel Ford HutmanText me!In today's episode, Rachel Ford Hutman and I talk through her journey in media relations, starting Ford Hutman Media and thriving through brand awareness in the life sciences space. Rachel Ford Hutman is the Founder and CEO of Ford Hutman Media. With 15+ years of communications experience at leading global PR agencies and a senior comms role at IBM, she created the agency to provide industry-leading media relations and thought leadership to elite life science companies across the globe. Clients range from venture-backed startups to large cap public companies. Rachel started her career as...
2023-08-2919 min
The BioWorld Insider PodcastThe struggle is real: The first half of 2023 was an uphill climb Guests Karen Carey, BioWorld's managing editor, and Mike Ward, Clarivate's global head of Life Sciences and Healthcare Thought Leadership, discuss the deals, financing and M&A landscape for the first half of 2023 and how U.K. biopharmas are faring post Brexit.
2023-08-1625 min
The BioWorld Insider PodcastThe biosimilars challenge to Humira revs upGuests BioWorld Regulatory Editor Mari Serebrov and Tom Newcomer, Samsung Bioepis vice president and head of U.S. market access, discuss the launch of biosimilars that are taking on a blockbuster.
2023-07-2117 min
The BioWorld Insider PodcastPreventing opioid overdoses with a smart patchBrad Holden, CEO of Resilient Lifescience, explains how the device works for overdoses as well as other potential applications for this new technology.
2023-06-0523 min
The John Rocha Channel NetworkDave Filoni Talks More AHSOKA Details, Star Wars Visions Vol 2, and BIG ANNOUNCEMENT - THE JEDI WAY LIVEOn this LIVE episode of THE JEDI WAY, hosts John Rocha and Laura Kelly welcome guest Kevin Smets to talk their thoughts on MAY THE 4TH and REVENGE OF THE FIFTH, their thoughts on STAR WAR VISIONS VOLUME 2, YOUNG JEDI ADVENTURES, AHSOKA, and RETURN OF THE JEDI 40th anniversary!________________________________________________________________________CHAPTERS:0:00 Intro and Rundown3:37 Dave Filoni and Jon Favreau's Recent Comments on Ahsoka27:37 Is Cad Bane Alive or Is He Dead?29:53 Skeleton Crew Will Have Amblinesque Vibes35:33 Heroes and Villains Star Wars Merchandise Unboxing39:10 Star Wars Visions Volume 2 REVIEW55:28 Young Jedi...
2023-05-071h 34
The BioWorld Insider PodcastBetter times ahead for the biopharma sector? Could be, the new numbers sayKaren Carey, BioWorld's managing editor and senior data analyst, and Tim Shannon, a general partner at Canaan, break down the numbers from first quarter of 2023. Hosted on Acast. See acast.com/privacy for more information.
2023-04-2428 min
The BioWorld Insider PodcastRadiopharmaceuticals: The next big disrupter?BioWorld Staff Writer Tamra Sami talks about the science behind radiopharmaceuticals, the supply chain vulnerabilities, the regulatory landscape, the patient journey and therapies in the pipeline. Hosted on Acast. See acast.com/privacy for more information.
2023-04-0513 min
The BioWorld Insider PodcastCambrian carves out a new niche as it works to keep people from getting sickJames Peyer, the CEO of Cambrian Biopharma Inc., talks about anti-aging therapies, a business model that fits the new field of geroscience. Hosted on Acast. See acast.com/privacy for more information.
2023-02-2128 min
The BioWorld Insider PodcastRethinking obesity: Fitness may be more directly linked to health than weight BioWorld Science Managing Editor Anette Breindl discusses her new analysis of multiple studies related to weight loss, metabolic health and fitness that in many ways go against mainstream theories about obesity. Hosted on Acast. See acast.com/privacy for more information.
2023-01-3121 min
suchislife#019| Exploring Solar,Turo, AirBnb, Sneaker Scammers,Real Estate In South Africa, Johnny DangWelcome back to our channel! In this episode, we're diving into a bunch of fascinating topics that are sure to spark your interest. We're taking a closer look at the exciting potential of solar energy and how it could shape our future. We're also giving our thoughts on the hit Netflix series 'Love is Blind' and how it's challenging our perceptions of love and relationships. Plus, we're talking about the pros and cons of using Turo and AirBnb for your next vacation, sharing our take on the real estate market in South Africa and also bringing attention to the...
2023-01-271h 55
Planet 8 PodcastEpisode 113: Looking back at 2022
Another year is in the books, and before we dive into 2023, the Planet 8 crew is taking some time to review the year that just passed. What films and TV shows did we enjoy? What surprised us? And what was disappointing? Oh heck, let's just say it: what was crap?! We go over it all, as well as dip into the future a bit with some speculation and anticipation for coming projects.
For the Sensor Sweep, each of us -Larry, Karen, and Bob - will talk about something cool we got for Christmas! Larry...
2023-01-081h 37
The BioWorld Insider PodcastLooking ahead to 2023: CEOs contemplate the new normalGuests Karen Zaderej, CEO of Axogen Inc., Sean Bohen, CEO of Olema Oncology Inc., Rob Ross, the CEO of Surface Oncology Inc., and Rob Etherington, the CEO of Clene Nanomedicine Inc., speak about adapting their companies to the market's new realities. Hosted on Acast. See acast.com/privacy for more information.
2022-12-0624 min
Live Long and Master AgingAnette Breindl: Is life extension a pipe dream?Extending lifespan is the goal of many in the field of human longevity, with myriad companies developing pharmaceuticals to target the key biological markers of aging. But which interventions actually work? A team of researchers at BioWorld recently delved into the latest science to try to make sense of the many clinal trials focused on the biology of aging. Anette Breindl is a co-author of the magazine's special report on aging, which also explores whether the large sums of money going into aging research are leading to real-world breakthroughs. In this LLAMA podcast interview Anette discusses her p...
2022-11-0226 minLive Long and Master AgingAnette Breindl: Is life extension a pipe dream?Extending lifespan is the goal of many in the field of human longevity, with myriad companies developing pharmaceuticals to target the key biological markers of aging. But which interventions actually work? A team of researchers at BioWorld recently delved into the latest science to try to make sense of the many clinal trials focused on the biology of aging. Anette Breindl is a co-author of the magazine's special report on aging, which also explores whether the large sums of money going into aging research are leading to real-world breakthroughs. In this LLAMA podcast interview Anette discusses her p...
2022-11-0226 min
The BioWorld Insider PodcastPsychedelic evolution: Mindset Pharma looks to change mental health treatmentJames Lanthier, the CEO of Mindset Pharma Inc., talks about developing next-generation psychedelic medicines to treat neurological and psychiatric disorders. Hosted on Acast. See acast.com/privacy for more information.
2022-09-2125 min
The BioWorld Insider Podcast$1B+ biopharma deals keep values afloat, even amid muted volumeBioWorld Senior Analyst Karen Carey chats about the collision of a volatile economic climate and big biopharma deals. Hosted on Acast. See acast.com/privacy for more information.
2022-09-0928 min
The BioWorld Insider PodcastExtending the human lifespanExtending the human lifespan, a BioWorld special report, examines the companies developing "Fountain of Youth" drugs. In this episode, the writers discuss this scientific holy grail. Hosted on Acast. See acast.com/privacy for more information.
2022-07-1941 min
ALIVE IN WONDERLAND. Über Bewusstsein und andere Verrücktheiten 🕳🐇🌈 Flashback #5.22 • Nach über einem Jahr Bali zurück nach Deutschland, Emotionale Intelligenz, selbstbewusst durch Tiefen gehen, Prioritäten richtig setzenMein vorerst letzter Monat auf Bali stand an und ich habe 3 Wochen eine neue Ausbildung in Energiearbeit gemacht, die super viel Zeit in Anspruch genommen hat. Es gab viele Herausforderungen, wo mich eine schon umhauen hätte können, aber ich kenn mich mittlerweile einfach sehr gut mit meinen Tiefen aus und kann mich durchguiden.
Es geht mal wieder ganz viel um Gefühle, über Emotionale Intelligenz, wie viel Selbstbewusstsein du bekommst, wenn du dich durch deine Tiefen und alle Gefühle navigieren kannst und natürlich auch ganz viel private stuff von mir und meinem letzten Monat a...
2022-06-0748 min
The BioWorld Insider PodcastNew therapies vie to change the fatal course of amyotrophic lateral sclerosisExecutives from Amylyx Pharmaceuticals Inc. and Clene Inc., along with a key Penn State ALS expert, discuss what the future of medicine holds for patients. Hosted on Acast. See acast.com/privacy for more information.
2022-06-0333 min
The BioWorld Insider PodcastBiopharma's correction? 2022 1Q investments are both up and downBioWorld Senior Analyst Karen Carey explores the newest data and where it is leading. Hosted on Acast. See acast.com/privacy for more information.
2022-05-0217 min
The BioWorld Insider PodcastWho advises the CDC on big COVID decisions?Infection control expert William Schaffner of the Vanderbilt University School of Medicine joins to discuss the CDC's Advisory Committee on Immunization Practices and how COVID-19 put the committee's schedule into overdrive.
2022-02-2324 min
The BioWorld Insider PodcastLong COVID: Potentially the next public health crisis Senior Science Editor Anette Breindl goes in depth about how long COVID-19 emerged and is being defined. Hosted on Acast. See acast.com/privacy for more information.
2022-02-1423 min
The BioWorld Insider PodcastWhat happens when your inventor is an artificial intelligence?Guests Ryan Abbott, a professor of law and medicine, as well as the leader of the Artificial Inventor Project, and Jim Belfiore, senior vice president of innovation at Clarivate plc, have a discussion about the brave new world AI is creating. Hosted on Acast. See acast.com/privacy for more information.
2021-12-1429 min
The BioWorld Insider PodcastAnother record year for biopharma financings bodes well for 2022A conversation with Kleanthis Xanthopoulos, a co-founder and executive chairman of Shoreline Biosciences, and Joe Hernandez, CEO and executive chairman of Blue Water Vaccines, who have founded or led eight health care and pharmaceuticals companies. Hosted on Acast. See acast.com/privacy for more information.
2021-12-1018 min
The BioWorld Insider PodcastAduhelm's hard lessons and what it means for other Alzheimer's drugsInsights into the controversial drug come from guests Michael Agadjanyan, president of Nuravax Inc., which is developing antibodies for preventing Alzheimer's and Parkinson's diseases, along with Robert Glanzman, chief medical officer of Clene Nanomedicine Inc. Hosted on Acast. See acast.com/privacy for more information.
2021-12-1032 min
The BioWorld Insider PodcastSupply Chain Geeky: Managing through the challenges of COVID-19 with an eye to what's at stake Paul Testa, executive vice president for operations and supply chain at Tokyo-based Kyowa Kirin, on the dramatic importance of continuity, reliability of supply, business process and automation. Hosted on Acast. See acast.com/privacy for more information.
2021-12-0924 min
The BioWorld Insider PodcastRegulatory Gemish: COVID-19's big impacts on the FDA and beyondPeter Pitts, president of the Center for Medicine in the Public Interest, on how government regulation seems like a slow but in actuality moves more quickly than understood. Hosted on Acast. See acast.com/privacy for more information.
2021-12-0928 min
The BioWorld Insider PodcastReality check: How did industry develop COVID-19 vaccines and drugs so fast?BioWorld Regulatory Editor Mari Serebrov puts the pandemic and the science into perspective. Hosted on Acast. See acast.com/privacy for more information.
2021-10-2616 min
The BioWorld Insider PodcastMerck's new COVID-19 pill will save lives, but at what price?Joseph Allen, executive director of the Bayh-Dole Coalition, explains how molnupiravir, from Ridgeback Biotherapeutics, and partner Merck & Co. Inc., may have never had a chance to move out of the university onto pharmacy shelves without the government's support. Hosted on Acast. See acast.com/privacy for more information.
2021-10-1828 min
Ideas to InnovationCOVID-19: Fighting a Global Pandemic with InnovationCOVID-19 is an enormous global challenge that has required an unprecedented level of engagement by stakeholders within pharma, research and policy. While SARS-CoV-2 emerged as a novel virus to which humans had no immunity, infection control measures have been deployed and existing as well as new and emerging technologies are being leveraged to speed the development of new treatments and therapies. Clarivate partnered with pharma in an international effort to bring life-saving vaccines to market. Joining us in this new episode of Ideas to Innovation are Clarivate experts Danielle Waterman, Senior Quality Specialist, Lynn Yoffee, Publisher...
2021-09-2945 min
The BioWorld Insider PodcastNewly approved cervical cancer drug Tivdak gives patients a new optionThe approval of antibody-drug conjugate Tivdak (tisotumab vedotin) for treating cervical cancer and the future of Genmab A/S are the subjects with the company's president and CEO, Jan van de Winkel. Hosted on Acast. See acast.com/privacy for more information.
2021-09-2418 min
The BioWorld Insider PodcastDNA vaccines: a better path to taming the pandemic?An in-depth conversation with Lucio Rovati, CEO and chief scientific officer of Italy's Rottapharm Biotech as they tackle the new world of DNA vaccines. Hosted on Acast. See acast.com/privacy for more information.
2021-09-1726 min
The Licensing MixtapeS3 E7: Bioworld Presents... Cultivating HappinessJennifer Staley and Beth Taylor of Bioworld share what keeps the team positive and optimistic—and why it’s so important for licensing success.
2021-09-1318 min
The BioWorld Insider PodcastRising to the COVID-19 challenge, clinical trials evolve Laurie Halloran, president and CEO of Boston-based Halloran Consulting, shares her thoughts on the impact of COVID-19 on clinical trials.
2021-09-0224 min
Blind Politics with Dr. A.J. NolteA Deep Dive into the Delta Variant with Mari Serebrov: 9/1/21Our guest, Mari Serebrov, has been tracking COVID since day one through her work as a regulatory editor with BioWorld. In this episode, she talks with Dr. Nolte about the impact of the delta variant and the means we have to fight against it.
2021-09-0140 min
The BioWorld Insider PodcastA 'Revolution' in drugging the undruggable hits a speed bump but motors onMark Goldsmith, Revolution Medicines Inc. president, CEO and chairman, talks about grappling with RAS mutations. Hosted on Acast. See acast.com/privacy for more information.
2021-08-2031 min
The BioWorld Insider PodcastAs dementia cases grow, biomarkers and new therapies key to unlocking treatment Howard Fillit, founding executive director and chief science officer at the Alzheimer's Drug Discovery Foundation, shares his insights on the impact of financial investments driving these therapies.
2021-07-3034 min
The BioWorld Insider PodcastAs biopharma deals keep pace, M&A volumes languishBiopharma deal-making activity, a closely watched marker of industry health, was alive and well in the second quarter. BioWorld Senior Analyst Karen Carey sifts through the numbers. Hosted on Acast. See acast.com/privacy for more information.
2021-07-0914 min
The BioWorld Insider PodcastIteos brings Glaxosmithkline a third checkpoint-targeting antibody in a $2B deal Michel Detheux, president and CEO of Iteos Therapeutics Inc., discusses what his company brings GSK in a massive new deal. Hosted on Acast. See acast.com/privacy for more information.
2021-06-1612 min
The BioWorld Insider PodcastFinally, a new medicine for Alzheimer's diseaseBiogen's vice president of global and U.S. medical affairs for Alzheimer's disease offers insight into Aduhelm. Hosted on Acast. See acast.com/privacy for more information.
2021-06-1009 min
The BioWorld Insider PodcastThe BioWorld Insider Podcast - trailerBreakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma's dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. The BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is changing how we all live. Join us each week for a new conversation. Hosted on Acast. See acast.com/privacy for more information.
2021-06-0400 min
The Licensing MixtapeLicense Global x Bioworld - Episode 2: Connecting Fans at RetailNavigating the consumer engagement landscape is more challenging than ever. With new platforms emerging every day, consumers have options on where to engage. Bioworld understands that and is meeting the fans wherever they are. This makes it easier for their retail and brand partners to succeed.
McKenna Morgan, digital editor, License Global is joined by Beth Taylor, Jennifer Staley, Sean Parnell, Chad Neurenberg and Casey Hulse of the Bioworld team to discuss how Bioworld connects with fans at retail.
2021-05-1724 min
The Licensing MixtapeLicense Global x Bioworld - Episode 1 - Powering FandomBioworld's Jennifer Staley and Beth Taylor join License Global's Bibi Wardak and McKenna Morgan for an in-depth discussion on fandom, the creativity it fuels and how Bioworld has become a fan-favourite from gaming to movies, anime and beyond.
2021-02-2226 minThe Licensing MixtapeS1 E9: Bioworld's Fan First Approach to LicensingBioworld Merchandising’s Jennifer Staley and Beth Taylor highlight how the company’s “Fandom Forever” approach has redefined the licensing business in this special Festival of Licensing episode.
2020-10-0528 min
iSmart PodcastThe art of telling the story with Rachel Ford Hutman, Founder and CEO of Ford Hutman MediaRachel is a global health industry connector and creative problem solver. She has worked on some of the world's biggest therapies and medical technologies of all time, including the first RNAi therapy (Alnylam’s ONPATTRO), the first therapy for DMD (Sarepta’s EXONDYS 51), the first technology in the world to personalize insulin 24 hrs. a day (Medtronic’s MiniMed 670G), IBM's AI launch into healthcare (Watson Health) and Google's sister life science company (Verily). She has counseled some of the most well-known health/ technology organizations and developed communications strategies for the world's biggest brands (Google, Johnson & Johnson, Medtronic, Pfizer, IBM, Best B...
2020-09-2200 min
IDEA Collider: Innovation & Asymmetric Learning in PharmaIDEA Collider | Daphne ZoharPureTech Health is an advanced, clinical-stage biopharmaceutical company developing novel medicines targeting serious diseases that result from dysfunctions in the nervous, immune, and gastrointestinal systems (brain-immune-gut or the “BIG” axis), which together represent the adaptive human systems. PureTech Health is at the forefront of understanding and addressing the biological processes and crosstalk associated with the BIG axis. By harnessing this emerging field of human biology, the Company is pioneering new categories of medicine with the potential to have great impact on people with serious diseases. PureTech Health is advancing a rich pipeline that includes multiple post human proof-of-concept studies and...
2020-08-0645 min
Health Unchained PodcastEp. 65: Software Development Consulting - Sam Schutte (CEO Unstoppable Software)Sam Schutte is the founder and CEO of Unstoppable Software, Inc. (https://unstoppablesoftware.com), a custom software development company that helps clients build systems to automate workflow and implement digital transformation. We talked about the challenges his clients face in an ever-changing technology landscape.
Special intro on Racial Injustice by Police
Visit for more information: https://blacklivesmatter.com/resources/
Disclaimer: Remember, the Health Unchained podcast is for informational and entertainment purposes only and we are not providing any sort of legal, financial, or medical advice. Please do your own research and due diligence before making any important decisions related to...
2020-06-071h 07
Health Unchained PodcastEp. 65: Software Development Consulting - Sam Schutte (CEO Unstoppable Software)Sam Schutte is the founder and CEO of Unstoppable Software, Inc. (https://unstoppablesoftware.com), a custom software development company that helps clients build systems to automate workflow and implement digital transformation. We talked about the challenges his clients face in an ever-changing technology landscape. Special intro on Racial Injustice by Police Visit for more information: https://blacklivesmatter.com/resources/Disclaimer: Remember, the Health Unchained podcast is for informational and entertainment purposes only and we are not providing any sort of legal, financial, or medical advice. Please do your own research and due diligence before making...
2020-06-071h 06
MuggleCast: The Harry Potter Re-Read Podcast#444: Harry Potter Gift Guide Extravaganza 2019
The Potter Collector joins us for MuggleCast’s Harry Potter Gift Guide!
Harry Potter: The Exhibition is now open in Lisbon, Portugal!
Harry Potter Holiday Gift Guide: What were some of the biggest items to debut in 2019?
The Potter Collector talks Nimbus 2000, Mystery Wands from Walmart and OutofPrint.com
Andrew: Hallmark has official Harry Potter ornaments (Hogwarts Castle Tree Topper) as well as a Golden Snitch Coffee Mug and Gringotts Vault Piggy Bank
Eric: LEGO is always a safe bet for any Potter fan (Hogwarts Full Set, Hogwarts Express and Grindewald’s Escape) and so are PUZZLES from the New York...
2019-11-251h 22
Alzheimer's SpeaksChallenges in Alzheimer's Drug DevelopmentToday Alzheimer's Speaks Radio Host, Lori La Bey is going to talk with Dr Elliot Goldstein, with ProMIS Neurosciences about a highly awaited Phase 3 trial and the challenges in Alzheimer's drug development. Further Infomration on ProMIS Neurosciences Website: www.promisneurosciences.com Additional Resources: https://alzheimersnewstoday.com/2018/01/11/study-shows-promis-alzheimers-therapy-attacks-only-harmful-protein-in-brain/ http://www.bioworld.com/report/BWIS03052018PromisNeurosciences.pdf For Additional Resources fromAlzheimer's SpeaksSupport this Show: https://alzheimersspeaks.com/donate-now/See omnystudio.com/listener for privacy information.
2018-04-0359 minAlzheimer's SpeaksChallenges in Alzheimer's Drug DevelopmentToday Alzheimer's Speaks Radio Host, Lori La Bey is going to talk with Dr Elliot Goldstein, with ProMIS Neurosciences about a highly awaited Phase 3 trial and the challenges in Alzheimer's drug development.
Further Infomration on ProMIS Neurosciences
Website: www.promisneurosciences.com
Additional Resources:
https://alzheimersnewstoday.com/2018/01/11/study-shows-promis-alzheimers-therapy-attacks-only-harmful-protein-in-brain/
http://www.bioworld.com/report/BWIS03052018PromisNeurosciences.pdf
For Additional Resources fromAlzheimer's SpeaksSupport this Show: https://alzheimersspeaks.com/donate-now/See omnystudio.com/listener for privacy information.
2018-04-0359 min
Jedi News NetworkGalactic Fashion: Episode 28Galactic Fashion is a monthly podcast dedicated to Star Wars and geek fashion, hosted by Johnamarie Macias and Teresa Delgado and part of the Jedi News Network. In episode 28, the two ladies talk about the Force Friday products released by Her Universe, Bioworld, ThinkGeek, and Loungefly. They also bring you the latest updates from Po-Zu, UtinniBikini, and Elhoffer Design as well as discuss the new collections from Jamberry and Cargo Cosmetics. For this month's episode, Johnamarie and Teresa had planned to interview Mari R. Cole (@TweetedFromMars, @sentfrommars), but since she recently went into labor, we send her...
2017-09-271h 02
Jedi News NetworkGalactic Fashion: Episode 24Galactic Fashion is a monthly podcast dedicated to Star Wars and geek fashion, hosted by Johnamarie Macias and Teresa Delgado and part of the Jedi News Network. In episode 24, the two hosts talk about the latest releases from Her Universe, the upcoming Hoth collection from Bioworld, the Harry Potter inspired fitness line from Castle Corsetry, and much more! Johnamarie and Teresa also interview (22:50) the winners of the Her Universe Fashion Show 2016: Hannah Kent (@pixel_stitcher), Camille Falciola (@frakkinfrocks), and Jesse Thaxton (@amayademorte). They talk about the Wonder Woman fashion collection from Her Universe and Hot Topic, their experiences at...
2017-05-312h 01